Contact Us

Fill in the contact form opposite and we will get back to you shortly. Alternatively use the contact details listed below
02921 845852
Wales Cancer Research Centre,
Room 1TB2 31,
First Floor Main Building,
University Hospital of Wales,
Cardiff, CF14 4XN
16 Jul

New Associate Directors

Associate directors

We are delighted to be able to announce that we have successfully completed our search for Associate Directors of the Wales Cancer Research Centre.

We had the luxury of selecting from amongst an outstanding cohort of excellent researchers who expressed an interest, the following new Associate Directors:

Prof. Duncan Baird, Cardiff University

Prof. John Staffurth, Velindre Cancer Centre

Dr. Sunil Dolwani, Cardiff and Vale University Health Board

The selection panel felt that they will provide the optimum blend of skills and experience to help move WCRC forward, in the coming years and we are confident that, individually and collectively, they will be highly influential in ensuring the sustainability of cancer research, across Wales, for the foreseeable future.

Prof John Chester said, “They will work closely with the Centre’s Executive Committee and with me, as Director.  Amongst the most important immediate roles will be to start work on updating our strategy for our next bid for on-going funding, commencing in 2020, which is due to be submitted early next year.

“I’m sure you’ll want to join me in welcoming Duncan, John and Sunil to their new roles and to wishing them every success.

“I am very grateful to all who have been contacted me about this process, for various reasons.  The high level of interest generated, in many quarters, has been one of the clearest indications, so far, of the importance of the centre to the cancer research community in Wales.”

We were extremely lucky to have such a large number of high-calibre people expressing an interest.  Any of them would have made an excellent Associate Director and we shall be trying to persuade each of them to let us take advantage of their enthusiasm in other ways, providing them with opportunities to be involved in other important leadership activities which will help us move forwards.

Prof Chester added, “My only disappointment is that we haven’t achieved the extent of diversity I had hoped for in the Associate Directorial team – we had no expressions of interest from outside Cardiff, none from non-medical healthcare professionals and the number of female applicants was small.  I am determined that the Associate Directors, the Centre Executive Committee and I will address this as a priority, in the remaining 20 months of the current funding period, and beyond.”

As always, we welcome your thoughts on these, or any other issues relevant to the Wales Cancer Research Centre.